UK 09:15 Wednesday, 7 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Cloudtag (CTAG) lied not once but twice by RNS last week so it repeatedly lied to investors. Either Nomad Cairn was in on the lies (plural) in which case it should lose its license or it too was lied too in which case it must resign. For the avoidance of doubt Cloudtag are liars and its CEO Amit Ben Haim signed off on the release. So he is a liar too. I invite both to sue me for libel and if Cairn won't quit it is then complicit in the lying so it can sue me too. Over to you liars... On Wednesday 7th Cloudtag Inc issued the following lie via an RNS titled “Movement in Share Price”
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
